Skip to main content
KOTRA INDUSTRIES BERHAD logo

KOTRA INDUSTRIES BERHAD — Investor Relations & Filings

ISIN · MYL0002OO009 BURSA Manufacturing
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-05-17 Interim / Quarterly Rep…
Country MY Malaysia
Listing BURSA

About KOTRA INDUSTRIES BERHAD

https://www.kotrapharma.com/

KOTRA INDUSTRIES BERHAD is an investment holding company engaged in the development, manufacturing, and trading of pharmaceutical and healthcare products. Through its subsidiary, Kotra Pharma, it specializes in finished pharmaceutical products, including generic drugs, and nutraceuticals. Key product lines include Appeton, a range of health supplements; Axcel, focusing on oral and topical preparations for paediatric, dermatological, anti-infective, and gastroenterological care; and Vaxcel, specializing in sterile injectable pharmaceutical products for anti-infective, gastroenterology, anti-coagulant, anaesthesia, and anti-emetic applications. The company also offers respiratory devices like Arite, antifungal treatments such as Creobic Cream, and over-the-counter pain relief with AxPain. It is recognized as a leading producer of pharmaceutical products, committed to promoting a healthier future.

Recent filings

Filing Released Lang Actions
Quarterly rpt on consolidated results for the financial period ended 31/03/2026
Interim / Quarterly Report Classification · 95% confidence The document is titled “Quarterly Report on Consolidated Results for the Third Financial Quarter Ended 31 March 2026.” It contains condensed consolidated financial statements (profit or loss, financial position, cash flows, changes in equity) along with explanatory notes prepared under MFRS 134 for interim reporting. It provides actual financial data for a quarter, consistent with an Interim/Quarterly Report. Therefore, it should be classified as IR (Interim/Quarterly Report). 9M 2026
2026-05-17 English
KOTRA - Notice of Book Closure
Notice of Dividend Amount Classification · 98% confidence The document is a "Notice of Book Closure" announcing a single tier interim dividend per share, with details on ex-dividend date, lodgment deadline, and payment date. This clearly fits the definition of a Notice of Dividend Amount (DIV).
2026-02-10 English
Quarterly rpt on consolidated results for the financial period ended 31/12/2025
Regulatory Filings
2026-02-09 English
Interim Dividend
Notice of Dividend Amount Classification · 92% confidence The document is an announcement of an interim dividend, providing dividend amount (9.0 sen per share), ex-date, record date, payment date, and registrar details. It does not contain full financial statements or management discussion. This matches the definition of a Notice of Dividend Amount (DIV).
2026-02-09 English
General Meetings: Outcome of Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is an announcement of the outcome of the Twenty-Sixth Annual General Meeting, detailing the poll voting results for each resolution. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). It is not an AGM presentation, annual report, or regulatory filing, but specifically the official vote results.
2025-11-26 English
Quarterly rpt on consolidated results for the financial period ended 30/09/2025
Regulatory Filings
2025-11-26 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.